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Introduction: Attempting to curb the rising epidemic of hypertension, South Africa implemented 
legislation in June 2016 mandating maximum sodium levels in a range of manufactured foods that 
contribute significantly to population salt intake. This natural experiment, comparing two African 
countries with and without salt legislation, will provide timely information on the impact of legislative 
approaches addressing the food supply to improve blood pressure in African populations. This article 
outlines the design of this ongoing prospective nested cohort study. Methods and analysis: Baseline 
sodium intake was assessed in a nested cohort of the WHO Study on global AGEing and adult health 
(WHO-SAGE) wave 2 (2014-2015), a multinational longitudinal study on the health and well-being of adults 
and the ageing process. The South African cohort consisted of randomly selected households (n=4030) 
across the country. Spot and 24-hour urine samples are collected in a random subsample (n=1200) and 
sodium, potassium, creatinine and iodine analysed. Salt behaviour and sociodemographic data are 
captured using face-to-face interviews, alongside blood pressure and anthropometric measures. Ghana, 
the selected control country with no formal salt policy, provided a nested subsample (n=1200) 
contributing spot and 24-hour urine samples from the SAGE Ghana cohort (n=5000). Follow-up interviews 
and urine collection (wave 3) in both countries will take place in 2017 (postlegislation) to assess change 
in population-level sodium intake and blood pressure. Ethics and dissemination: SAGE was approved by 
the WHO Ethics Review Committee (reference number RPC149) with local approval from the North-West 
University Human Research Ethics Committee and University of the Witwatersrand Human Research 
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ABSTRACT
Introduction: Attempting to curb the rising epidemic
of hypertension, South Africa implemented legislation
in June 2016 mandating maximum sodium levels in a
range of manufactured foods that contribute
significantly to population salt intake. This natural
experiment, comparing two African countries with and
without salt legislation, will provide timely information
on the impact of legislative approaches addressing the
food supply to improve blood pressure in African
populations. This article outlines the design of this
ongoing prospective nested cohort study.
Methods and analysis: Baseline sodium intake was
assessed in a nested cohort of the WHO Study on
global AGEing and adult health (WHO-SAGE) wave 2
(2014–2015), a multinational longitudinal study on the
health and well-being of adults and the ageing process.
The South African cohort consisted of randomly
selected households (n=4030) across the country. Spot
and 24-hour urine samples are collected in a random
subsample (n=1200) and sodium, potassium,
creatinine and iodine analysed. Salt behaviour and
sociodemographic data are captured using face-to-face
interviews, alongside blood pressure and
anthropometric measures. Ghana, the selected control
country with no formal salt policy, provided a nested
subsample (n=1200) contributing spot and 24-hour
urine samples from the SAGE Ghana cohort (n=5000).
Follow-up interviews and urine collection (wave 3) in
both countries will take place in 2017 (postlegislation)
to assess change in population-level sodium intake and
blood pressure.
Ethics and dissemination: SAGE was approved by
the WHO Ethics Review Committee (reference number
RPC149) with local approval from the North-West
University Human Research Ethics Committee and
University of the Witwatersrand Human Research
Ethics Committee (South Africa), and University of
Ghana Medical School Ethics and Protocol Review
Committee (Ghana). The results of the study will be
published in peer-reviewed international journals,
presented at national and international conferences,
and summarised as research and policy briefs.
CURRENT STUDY STATUS
Data collection for wave 2 (baseline for the
nested salt substudy) has been completed,
while data collection for wave 3 (first
follow-up of the nested salt substudy) will take
place in 2017 and is estimated to be complete
by the end of 2017. Further waves of data col-
lection are planned as part of the multicoun-
try, longitudinal WHO Study on global
AGEing and adult health (WHO-SAGE).
INTRODUCTION
Many adults consume more salt daily than is
recommended, contributing to the global
epidemic of hypertension and cardiovascular
disease (CVD).1 In low-income and
middle-income countries (LMIC), a dispro-
portionately rapid increase in hypertension is
Strengths and limitations of this study
▪ Rigorous random selection procedure based on a
sample designed to be nationally representative.
▪ Ongoing data collection within the WHO Study
on global AGEing and adult health (WHO-SAGE)
cohort to capture salt intake and disease.
▪ We were unable to identify the specific foods
contributing to salt intake in wave 2.
▪ Results may be less representative for the
smaller sample of adults aged 18–49 years.
▪ Nationwide implementation of salt regulations
precludes inclusion of a local control group.
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occurring without commensurate strategies to halt this
growth or mitigate the impact on CVDs and death.2 The
scale of the problem in South Africa is evident: among
six LMICs in one study, South Africa was shown to have
the highest prevalence of hypertension (78%) in adults
aged 50 years and older.3 4 Public health strategies are
being employed to reduce levels of hypertension, includ-
ing over 30 countries using legislative changes as part of
their salt reduction strategy to meet the WHO and
World Health Assembly salt target of 30% reduction in
population salt/sodium intake by 2025.5 6
South African researchers found that non-
discretionary salt intake (salt already in processed foods)
is estimated to contribute around 60% of the overall
daily salt intake, primarily from bread and meat pro-
ducts.7 As a result of this research, in March 2013 South
Africa was the first country to legislate for mandatory
reformulation of a range of foods,8 setting maximum
sodium levels (mg per 100 g) in targeted processed
foods (bread 400 mg; breakfast cereal 500 mg; butter
and margarine 550 mg; potato crisps 650 mg; salty
snacks 800 mg; raw sausage 800 mg; processed meat
850–950 mg; instant noodle mix 1500 mg; dry soup
powder 5500 mg; and stock concentrate 18 000 mg), all
identified as contributing significantly to sodium intake
in the South African population.7 9 10 The first phase of
sodium legislation was implemented in June 2016, with
further reductions required in sodium levels across food
categories by June 2019.11 The legislation is predicted to
decrease nationwide salt intake by 0.85 g/day;12 reduce
annual CVD deaths by 11%; save the government US
$51.25 million/year and prevent 2000 cases of poverty
annually as a result of saving households more than US
$4 million/year in out-of-pocket medical expenses.13
A number of collateral issues arise regarding salt
intake, such as salt being the main source of iodine forti-
fication, so that successful campaigns to reduce salt
intake would have the potential to result in reduced
iodine intake.14 Another consideration is that dietary
sodium-to-potassium ratio may predict CVD mortality
better than sodium intake alone.15 Additionally, debate
continues on the efficacy of legislative versus non-
legislative approaches to population salt reduction,8 16 17
including the mechanisms to monitor and enforce such
legislation.18 From a public health perspective, the
major challenge is to evaluate the effects on population
health. This paper discusses one effort undertaken to
assess a number of health impacts following the sodium
legislation in South Africa in comparison to Ghana, an
African country with no sodium legislation, through
implementation of a large health study in each country.
METHODS AND ANALYSIS
Objectives of the research
The primary aim of this study is to evaluate the impact
of the sodium legislation on population sodium intake
and blood pressure (BP). Secondary objectives are to
assess: (1) the relationship between sodium and potas-
sium levels and BP prelegislation and postlegislation; (2)
the impact of the sodium legislation on population
iodine intake; and (3) the use of spot urine samples as a
proxy for 24-hour urine sample collection to measure
population salt excretion in a nested biochemical
analysis.
Theory of change
In order to evaluate the impact of policy on the desired
outcome, it is critical to appreciate the steps required
between policy implementation and change in the
outcome. Gertler et al19 refer to this as the theory of
change (how an intervention is supposed to deliver the
required results) and propose various models that can
be used for this purpose. One of these models, ‘the
Results Chain’, has been adapted for our purposes
(figure 1) to explore the causal logic underlying the
expectation that sodium legislation will impact BP and
CVD. The model shows the inputs (legislation and edu-
cation), activities (food industry formulation changes;
also with monitoring of educational/media activities),
outputs (change in sodium levels in foods; changes in
awareness about dietary salt and hypertension from any
educational activities) and outcomes (reduced dietary
intake and urinary excretion of salt, reductions in BP,
and finally, reductions in CVD mortality, morbidity and
associated healthcare spending).
Inputs, activities and outputs collectively describe the
implementation of the legislation and activities planned
by the South African National Department of Health
(NDoH) and others. These are the subject of monitor-
ing and process evaluation. The outcomes (results) are
the subject of impact evaluation and the main focus of
this study. However, the impact evaluation needs to be
informed by an assessment of the implementation in
order to correctly interpret the results.19 For example,
without knowing whether the targeted food products
comply with the legislation, it would be difficult to attri-
bute change in salt intake to the sodium legislation. As
such, a multidisciplinary group including the NDoH will
be undertaking these assessments, with contributions
from the SAGE collaboration. Gertler et al19 also suggest
that development of the Results Chain model promotes
exploration of these assumptions and risks within the
proposed causal logic. The assumptions and risks are
further explored within the discussion.
Ghana as a comparison group
Gertler et al19 also recommend including a comparison
group. Ideally, this would be a South African group
matched on all characteristics and exposures but not
affected by the legislation, with data collected at the
same time as those who would be affected by the legisla-
tion. However, since the legislation is in force across the
whole country, this is not possible. Neighbouring coun-
tries such as Lesotho, Swaziland, Botswana, etc, would
also not be good candidates for a comparison group as
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many of the South African food manufacturers export
goods to these countries under the South African
Development Community (SADC) Regional Free Trade
agreement (2008). South Africa is the major source of
processed snack food in the SADC region,20 providing
around 80% of the processed food in Zambia, Namibia
and Botswana.21 These countries then would most likely
be affected by the spillover of the South African sodium
legislation. SADC countries form over 80% of South
Africa’s export market, with exports to the rest of Africa
consisting mainly of vehicles and machinery.22 As such,
Ghana, a non-SADC country and the only other African
country to implement WHO-SAGE, was selected as the
comparator country. Ghana’s adult population is also
afflicted by a high prevalence of hypertension (up to
48% of adults generally23 and 54% of adults 50+ years of
age), increasingly poor risk factor profiles (diet, obesity,
physical activity), and poor rates of hypertension aware-
ness and control.3 In terms of salt intake, the Ghana
Health Service has focused primarily on eradication of
iodine deficiency through salt iodisation and educa-
tion.24 At the same time, efforts are underway to boost
the salt production industry in Ghana as a method of
economic development.25 26 Salt intakes appear compar-
able between Ghana and South Africa with studies sug-
gesting that both countries have intakes between 2.3 and
5.5 g sodium/day (equivalent to 5.8–13.8 g salt/day),
and higher intakes in urban compared with rural popu-
lations.27 While there have been some efforts to lower
salt intake in community interventions,28 until now
there appears little evidence to suggest that either man-
datory or voluntary sodium targets exist between govern-
ment and the food industry in Ghana to promote a
reduction in population salt intake. However, as in
South Africa, it will be critical to monitor activities in
Ghana that could influence salt intake between waves 2
and 3 of data collection. There are some risks in taking
this pragmatic approach, although local experts will
provide ongoing and active assessments in both coun-
tries between study waves, and this study team will
undertake rigorous comparisons of the nested study
groups at waves 2 and 3 to determine the feasibility of
this research strategy.
Study population
Random sampling procedure
WHO-SAGE is a multinational study examining the
health and well-being of adult populations and the
ageing process. Two waves of this longitudinal study have
been completed in China, Ghana, India, Mexico, Russia
and South Africa.29 Further details about WHO-SAGE
can be found via the WHO website (http://www.who.
int/healthinfo/sage/cohorts/en/) including access to
data from SAGE wave 0 (2002–2004), SAGE wave 1
(2007–2010) and SAGE wave 2 (2014/2015) following
the completion of data cleaning. SAGE wave 3 will be
implemented in 2017, with fund-raising for SAGE wave 4
and beyond ongoing. Evaluation of the health effects of
this sodium policy on South African adults, in compari-
son to Ghanaian adults, is conducted using a nested
study design in waves 2 and 3, with monitoring of the
nested cohort continuing in subsequent waves of data
collection.
In total, 42 464 respondents were recruited across the
six countries for wave 1 (2007–2010), including 4223
respondents in South Africa (9% 18–49 years; 40% 50–
59 years; 51% 60+ years). Wave 1 respondents were
recruited from selected probability sampled enumer-
ation areas (EAs) using a multistage cluster sampling
strategy, with stratification by province, residence and
race.
The wave 2 sampling strategy was designed to account
for expected attrition as a result of participants having
moved house or died since wave 1, especially given that
over half of the sample were already above 60 years of
age in 2007. All wave 1 households were visited for wave
2 data collection (including a verbal autopsy for those
participants no longer alive). Replacements for sample
attrition used a systematic sampling approach to ran-
domly select new households using EA aerial
Figure 1 Results Chain model
for the SAGE nested salt
substudy. Note: adapted from
Gertler et al.19 *Discretionary and
non-discretionary salt use.
Charlton K, et al. BMJ Open 2016;6:e013316. doi:10.1136/bmjopen-2016-013316 3
Open Access
group.bmj.com on December 1, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
photographic maps on which dwellings are clearly
visible, starting at a random point on the periphery of
the EA and following predetermined routes.
Households were then classified into the following
mutually exclusive categories: (1) SAGE wave 1 follow-up
households with one or more members aged 50 years or
older targeted for selection; (2) new households with
one or more members aged 50 years or older; (3) SAGE
wave 1 follow-up households which include residents
aged 18–49 targeted for selection or (4) new households
which include residents aged 18–49. Younger adults are
allowed to ‘age-in’ to the older adult group, with tar-
geted refreshing of the youngest ages (18–23) in the
younger adult sample.
The sampling method used in SAGE Ghana wave 2
followed a similar design, based on the 2003 World
Health Survey/SAGE wave 030 with primary sampling
units (PSUs) stratified by region and location (urban/
rural). Selection of the PSUs was based on proportional
allocation by size using the same follow-up and random
systematic sampling method as South Africa.
Selection and data collection in the nested cohort
Both South Africa and Ghana include between 3500 to
4500 households for SAGE’s main survey sample. The
samples selected for urine collection (n=1200 in each
country) from waves 2 and 3 of the main study are of
adults aged 18+ years, with the final distribution in the
main and nested studies reflecting the weighting towards
recruiting more adults aged 50+ years. In South Africa,
the nested study respondents were sampled from among
the first wave 2 households visited within each probabil-
ity sampled EA (day 1 in the EA). This approach was
taken to prioritise the shipment of all collected urine
samples to a central laboratory (Global Clinical and
Viral Laboratory, Durban) within 3 days of collection
while maintaining a cold chain regardless of where
urine collection took place. This was necessary as there
were no decentralised facilities available to freeze urine.
The SAGE South Africa team used 20 survey teams (one
nurse and three interviewers per team) simultaneously
collecting data and urine/blood samples from respon-
dents across all provinces in the country over a 5-month
period (August to December 2015).
Selection of the nested study sample in Ghana dif-
fered slightly from the one in South Africa. All urine
samples were collected by just four fieldwork teams (one
research assistant and four interviewers per team)
moving region to region over a 10-month period
(September 2014 to June 2015). To facilitate this
approach, EAs were randomly selected, with stratification
by urban/rural, from the three geographical areas
(savannah, forest and coastal) of Ghana and designated
‘urine EAs’ from which the target 1200 respondents
were recruited.
Inclusion criteria for urine collection were: respond-
ent must be part of the WHO-SAGE cohort, with no
indication of urinary incontinence or other condition
that could impede 24-hour urine collection; and if
female, not menstruating, pregnant or breast feeding on
the day of collection. All respondents who provided
samples in wave 2 will be approached again in wave 3 in
both countries, with procedures as described earlier for
replacement and refreshment of the sample.
Study measures included in WHO-SAGE
All survey teams are trained with support from WHO
Geneva, with survey teams using standardised house-
hold, individual and proxy questionnaires, anthropom-
etry, blood sampling, BP and physical function tests as
described previously in SAGE wave 1.29 Study measures
are listed in table 1 and translation and back-translation
protocols are in place for the survey instruments.
Interviewers speak the respondents’ home languages
with consent forms available in the most widely spoken
languages for each area.
Table 1 Primary and secondary outcome measures
Variable
Primary/
secondary
outcome
Method of
measurement
Sodium intake Primary 24-hour urinary sodium
excretion
Blood pressure Primary Validated, automated
wrist BP monitor—
triplicate measure
Potassium
intake
Secondary 24-hour urinary
potassium excretion
Iodine status Secondary Urine iodine
concentration
Cigarette
smoke
exposure
Secondary Urine cotinine
concentration and
questionnaire
Medication use Secondary Questionnaire
Dietary salt
behaviour
Secondary Questionnaire*
Alcohol
consumption
Secondary Questionnaire
Physical
activity
Secondary Global Physical Activity
Questionnaire44
Body
composition
Secondary Height, weight, waist
and hip circumference
Quality of life Secondary WHO Quality of Life
instrument
(WHOQoL)45
*The dietary salt questionnaire consists of the following questions:
(1) Do you add salt to food at the table? (Always, rarely,
sometimes, often, never); (2) In the food you eat at home, salt is
added in cooking [always, rarely, sometimes, often, never); (3)
How much salt do you think you consume? (Far too much, too
much, just the right amount, too little, far too little, don’t know,
refused); (4) Do you think a high salt diet could cause a serious
health problem? (Yes, no, don’t know, refused); (5) Do you do
anything on a regular basis to control your salt or sodium intake?
(Yes, no, don’t know, refused).
BP, blood pressure; WHOQoL, WHO Quality of Life instrument.
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Urine collection in the nested study (waves 2 and 3)
The study protocol used for sodium determination in
24-hour urine samples followed the WHO/Pan
American Health Organization (PAHO) guidelines.31
Respondents were requested to collect all urine pro-
duced for 24 hours, excluding the first pass urine on day
1, but including the first urine of the following morning
(day 2) in a 5 L plastic container using 1 g thymol as
preservative. The spot sample was collected without pre-
servative from the second urine passed on day 1
(marking the start of the 24-hour collection) and dec-
anted into three 15 mL Porvair tubes (Porvair Sciences,
Leatherhead, UK), then kept in a thermoelectric cooler
box powered by the fieldwork vehicles and containing
ice packs to maintain a lowered temperature. The
24-hour sample was collected the next morning, total
volumes were recorded and aliquots (4×15 mL Porvair
tubes) generated with all samples then shipped to the
laboratory maintaining the cold chain using precooled
ice packs as a means to maintain temperature control.
When the samples arrived at the laboratory, the cooler
box was examined and the temperature of the samples
noted and recorded.
Owing to differences in available resources, duration
of data collection and logistical challenges presented by
each country, Ghana and South Africa used different
methods of urine preservation in wave 2. In Ghana, the
survey team kept urine samples in hospitals, clinics and
health centres with laboratory facilities in the EA in
which they were working. Samples were taken on ice to
the central university laboratory between the first and
fifth days of interviews in each EA. This was necessary as
there were limited options and resources for commercial
transport of samples within Ghana. Additionally, with
Ghana’s tropical climate and a smaller fieldwork team
than in South Africa, the possibility that samples may
stand for longer in a warmer climate prior to collection
necessitated the use of 37% hydrochloric acid (HCl;
AnalaR NORMAPUR) as a preservative added to both
the 24-hour (10 mL per 5 L collection container) and
spot urine (10 mL per 2 L collection container)
samples.
In South Africa, thymol preservative, a crystalline
natural derivative of the thyme plant, is used as it is
easier and safer to transport and handle than commonly
used liquid acids by the 20 operating fieldwork teams
and courier companies, many of which will not transport
liquid acids. In both countries, survey teams explain the
dangers of the preservatives to respondents, and are
trained in handling the preservatives and biological
materials. Both thymol and HCl have been shown to
prevent changes in urinary creatinine, sodium and
potassium concentrations for up to 5 days.32
Incomplete 24-hour urine collections are assumed if:
total volume ≤300 mL; or creatinine excretion
≤4 mmol/day (women) or ≤6 mmol/day (men).33 The
use of para-amino benzoic acid (PABA) has been sug-
gested as a more accurate method than creatinine to
validate 24-hour urine collection completeness.34
However, PABA recovery rate declines with age in
respondents older than 30 years.35 Considering this
together with the increased risk for non-compliance and
attrition due to the additional burden of remembering
to take the PABA pill 3 days before the urine collection,
as discussed in the WHO/PAHO guidelines for sodium
determination in 24-hour urine samples,31 PABA is not
used in this study.
Urine analysis
Sodium and potassium were determined using the indir-
ect ion-selective electrode method and creatinine ana-
lysed using the standardised urinary Jaffe kinetic
method (South Africa: Beckman Coulter Synchron
DXC600/800 System; Ghana: BioSystems Analyzer A25).
The WHO population target for salt intake is 5 g salt
(NaCl) per day, equivalent to urinary sodium excretion
85 mmol/24 hour. Urinary potassium should be
>70 mmol/24 hour, with a sodium-to-potassium ratio <1
shown to be protective for all-cause, cardiovascular and
ischaemic heart disease mortality.15 With the exception
of iodine, all South African samples were analysed at a
single laboratory in Durban (Global Clinical and Viral
Laboratory). In Ghana, with the exception of iodine, all
samples were analysed at a single laboratory in Accra
(University of Ghana Chemical Pathology Laboratory in
the School of Allied Health Sciences).
Urine samples for iodine analysis from both countries
were stored at −20° C and batch analysed using the
Sandell-Kolthoff method with ammonium persulfate
digestion and microplate reading36 at the North-West
University Centre of Excellence for Nutrition. The
laboratory participates successfully in the Program to
Ensure the Quality of Urinary Iodine Procedures
(EQUIP, US Centres for Disease Control and Prevention,
Atlanta, Georgia, USA).37 A median of <100 μg iodine/L
indicates population-level deficiency (there is no refer-
ence range for individuals).38
Even though there is no evidence that the addition of
preserving substances such as HCl and thymol affects
urinary iodine concentrations,39 we undertook testing to
examine the influence of adding thymol or HCl to
urine samples (n=20) on urinary iodine concentrations.
The results indicated no significant or relevant (below
assay coefficient of variation) differences when com-
pared with samples without added preservatives (results
not shown here).
Comparison of spot and 24-hour urine analyses
The following equations will be used to assess the accur-
acy of using spot urine samples to assess 24-hour urinary
sodium, potassium and iodine excretion: (1)
Tanaka;40 (2) Kawasaki41 and (3) INTERSALT.42 The
sensitivity of the formulae to estimate the measured
24-hour urinary creatinine, sodium and potassium excre-
tion will be assessed using the receiver operator charac-
teristic curve analysis. Multiple regression modelling will
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be conducted to determine whether new regression
models are more appropriate for use in African
populations.
BP measurements
Wrist-worn Omron BP devices were used to record three
sequential measures on the left arm (1 min between
each measure), with the wrist resting at the level of the
heart and the respondent seated with legs uncrossed.
The wrist BP devices are validated to the European
Hypertension Society International Protocol.43
Data capture, analysis and statistical power
All data were and will be captured using an electronic
data capture system and uploaded to a secure central
server within each country. Cleaning and analysis of
survey data are coordinated by the WHO. Based on the
modelled estimated reduction of 0.85 g salt per day as a
result of the legislation, with a current estimated South
African population salt intake of 8.1 g/day12 and a popu-
lation variance of up to 35 g/day based on previous pilot
data (unpublished), a sample size of 761 respondents
would give 80% power to detect a significant difference
(95% CI). Allowing for error in 24-hour sample collec-
tion (incomplete or missing samples) in this complex
field study, a target sample size of 1200 was chosen.
ETHICS AND DISSEMINATION
All respondents provide written informed consent prior
to taking part in the study. The study complies with the
ethical principles for medical research involving human
participants as per the Declaration of Helsinki.46
Baseline data collection (for this nested substudy as part
of wave 2) is complete and the results will be published
in peer-reviewed international journals, presented at
national and international conferences, and summarised
in research and policy briefs. Completion of the first
follow-up of the nested study (as part of SAGE wave 3)
in South Africa and Ghana is expected by December
2017. Dissemination of the final results will begin soon
thereafter. All de-identified data will be made available
in the public domain.
DISCUSSION
The WHO recommends that adults consume no more
than 5 g of salt per day47 while most South African
adults consume well above this level, with bread being
the single highest contributor to non-discretionary
sodium intake.7 In the light of the high prevalence of
hypertension within the country,3 the government’s bold
move to reduce sodium in bread, cereals, snacks, pro-
cessed meats, spreads, soups, stocks and gravy in 2016,
with further reductions mandated for 2019, is welcomed.
This intervention could significantly reduce the preva-
lence of hypertension, stroke and CVD in South Africa,
thereby substantially reducing healthcare costs to the
state and to individuals.12 13 However, successful
reduction of population level sodium intake through
legislation has yet to be demonstrated.
The need to simultaneously monitor both sodium
reduction and iodine status is required as, in South
Africa, universal salt iodisation has successfully eradi-
cated iodine deficiency.48 49 The two public health strat-
egies are compatible50 if ongoing surveillance informs
the adjustment of iodine levels in iodised salt as popula-
tion salt intake decreases.51 The assessment of salt beha-
viours will be interesting, as multiple strategies
accompany the sodium legislation, including mass
media campaigns such as SaltWatch, which is coordi-
nated by the Heart and Stroke Foundation South
Africa,52 and primary care health education activities
conducted by the South African (NDoH). All SAGE
countries will include the standard salt behaviour ques-
tions in waves 2 and 3 so that a cross-national compari-
son of salt behaviours will be possible between the six
LMIC countries.
Assumptions and risks in the causal logic
We make several assumptions within the implementation
portion of the Results Chain model (figure 1) including
the timely compliance of all manufacturers of the tar-
geted food products with the sodium legislation; and
that educational activities reach the intended
beneficiaries.
South Africa is now one of a number of countries with
mandatory sodium targets; others include Argentina,
Belgium, Bulgaria, Greece, Hungary, the Netherlands,
Paraguay and Portugal.6 18 Mandatory sodium targets in
Argentina (Act 26905) came into force in December
2014 for three food groups: (1) meat and meat pro-
ducts; (2) soups, dressings and canned foods; and (3)
farinaceous or starch containing products such as crack-
ers, cookies and bakery products.53 There are strict pen-
alties for not meeting the sodium regulations, ranging
from fines to the confiscation of food products, and sus-
pension of business for up to 5 years.53 A prepolicy
evaluation conducted in February 2014 comparing food
labels against the mandatory targets concluded that
most foods in Argentina were already meeting the target
sodium levels, though this differed by food category with
around half of the bakery products reviewed exceeding
the mandated sodium level.54 This high prelegislation
compliance may be explained by the successful
government-led programme ‘Less salt, more life’
initiated in Argentina in 2011, including voluntary agree-
ments with the food industry to lower sodium in foods
and extensive monitoring of both implementation (food
sodium testing in independent laboratories) and effect-
iveness (sodium intake surveys and urinary sodium meas-
urement).55 In contrast to this example is Belgium,
where mandatory sodium levels in bread were set in
1985, although in 2006 half of the bakers were still pro-
ducing bread with higher sodium levels, stating that
tighter regulation led to products being imported and
unfair competition from neighbouring European
6 Charlton K, et al. BMJ Open 2016;6:e013316. doi:10.1136/bmjopen-2016-013316
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countries.56 Only after an awareness campaign was direc-
ted specifically at bakers did compliance increase to
90% by 2008, 13 years after the legislation was
introduced.
Findings from Argentina also highlight that sodium
discussions often take place between government and
the bigger food companies and an ongoing challenge
will be to determine compliance with sodium targets in
small-sized and medium-sized food producers.54
These examples highlight the need for continued
compliance monitoring, an understanding of the
reasons for non-compliance, and clear interventions and
penalties for non-compliance, as it would seem that
compliance with legislation cannot be taken for granted.
Non-compliance by targeted food manufacturers or
increased salt levels in non-legislated food products (by
other food producers) are risks to undermining the
intended outcomes. Educational activities that do not
reach the intended beneficiaries are also a risk as they
may fail in the message to modify discretionary salt use.
Media campaigns to reduce salt can work,57 and the key
again will be in documenting and monitoring their
success. As a mitigation strategy for these risks, the
SAGE South Africa team is working closely with stake-
holders in government, academia, non-governmental
organisations and research organisations who are dir-
ectly involved in monitoring compliance and/or the
development, delivery and evaluation of salt and BP edu-
cational activities. In September 2016, stakeholders met
to develop a roadmap for the South African salt reduc-
tion strategy, with action points and a report due to be
published. The meeting serves as a foundation to coord-
inate and link efforts. The authors will continue discus-
sions with these stakeholders and are open to any
discussions that promote a thorough and valid evalu-
ation of the effectiveness of this important health policy.
Also, within the Results Chain model (figure 1),
several assumptions underlie achieving the results
including consumers purchase and consume the lower
sodium products; educational activities are effective in
changing behaviour to decreasing discretionary salt use;
reduced salt intake is accurately reflected in a single
24-hour urine collection; reduced salt intake leads to
reduced BP and ultimately a reduction in CVD events
and healthcare spending. There is strong evidence sup-
porting the final outcomes with high salt intakes asso-
ciated with increased risk of stroke and CVD58 59 and
population efforts to lower sodium intake producing
notable improvements in BP and deaths from stroke and
CVD.60 Naturally, this does not guarantee that we will
find the same outcome. WHO-SAGE is well placed to
continue follow-up in the South African cohort, as it has
been operational in South Africa since 2003 with wave 0
of data collection,29 and plans to continue data collec-
tion after wave 3 (2017) approximately every 4 years.
This provides an ideal opportunity to collect longer
term data on cardiovascular and stroke mortality and
morbidity in South Africa and Ghana.
In terms of acceptability of the lower sodium foods,
one systematic review suggests that sodium levels can be
reduced by up to 40% in bread and 70% in meat pro-
ducts without compromising consumer acceptability.61
Additionally, longer term exposure to lower salt foods
has been shown to increase preference for those foods
and decrease preference of higher salt alternatives.62 63
While it would appear that sodium regulations are
unlikely to modify consumer purchasing behaviour, the
WHO-SAGE South Africa team is also collaborating with
organisations able to monitor consumer food purchas-
ing patterns prelegislation and postlegislation.
There is evidence supporting salt reduction campaigns
change behaviour and impact salt intake. For example, a
community-based health education programme in Japan
successfully decreased salt intake by 2–3 g/day.57 A cam-
paign in the UK decreased discretionary salt use64 and
reduced overall salt intake by around 10%.65 Again,
monitoring and evaluation of educational activities
within South Africa will be important to determine their
effectiveness.
Finally, there is the question of whether one 24-hour
urine collection is sufficient to assess dietary salt intake.
There is little doubt that repeated 24-hour urine collec-
tion in an individual improves the accuracy to assess salt
intake, with more collections giving greater accuracy.66
However, repeated sampling may lead to refusals or
more incomplete samples67 producing underestimates
of salt intake.68 Additionally, Mente et al67 point out that
large studies reduce random error, so that average esti-
mates of salt intake from 24-hour urine collection across
a large number of people are reliable estimates for
groups, albeit less so for individuals. While repeated
24-hour urine collection may be feasible in smaller ran-
domised controlled trials, it can be impractical for larger
studies, especially in LMICs.69 Furthermore, 24-hour
urine collection remains the gold standard to measure
salt intake when compared with estimated intake from
casual or spot urine samples.70 Therefore, a single, well-
collected 24-hour urine sample appears a pragmatic
approach to take in this prospective cohort study of over
1000 participants in each of the two countries.
Limitations of the study
WHO SAGE is designed to investigate the health and
ageing process in older ages; therefore, the focus is on
adults aged 50 years and older. Although a smaller
sample of adults aged 18–49 years is included, the
results from this study may not be representative for
younger adult age groups. However, SAGE wave 1 data
showed that four in every five adults above 50 years of
age in South Africa are hypertensive,3 justifying a focus
on monitoring the effectiveness of the sodium legisla-
tion within this age group. The gold standard method
for estimating sodium intake is used (24-hour urinary
Na excretion), yet the lack of comprehensive dietary
assessment will not allow identification of major food
contributors to total salt intake. Another limitation is
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our ability to effectively monitor the food industry
adherence to the legislation. While we will work with key
stakeholders to jointly evaluate the degree of enforcement
observed and sodium content of food products, this is not
the primary aim of the study. One potential limitation
could be the choice of comparison group. Using Ghana
provides a reasonable choice with some similar demo-
graphic and epidemiological characteristics and without
formal national-level sodium legislation. While standard
training and interview techniques as well as survey instru-
ments were used, there was a difference of several months
in the time frame for wave 2 data collections in South
Africa and Ghana. It is unclear if this will impact the valid-
ity of comparisons. A clear analytical plan will be in place
to facilitate interpretation of results by WHO-SAGE,
SAGE-Ghana and SAGE-South Africa teams.
Strengths of the study
The comprehensive assessment of the ageing process
within SAGE, alongside the rigorous random selection
procedures employed, provides an ideal opportunity to
assess the effectiveness of this legislative public health
approach. Additionally, WHO SAGE is ideally placed for
ongoing data collection to include evaluation of the
planned 2019 legislative changes to further reduce
sodium levels in foods and collection of data on hard
end points such as cardiovascular-related mortality
which require a longer time frame. WHO-SAGE mea-
sures BP in each wave of data collection and will con-
tinue to do this. While urinary sodium analysis is
conducted only for waves 2 and 3 in the nested studies
in South Africa and Ghana, from wave 2 onwards, ques-
tions on discretionary salt use have been added to SAGE
for all respondents in each of the six countries. This will
provide valuable data on self-reported discretionary salt
behaviours as countries implement various strategies to
reduce population salt intake.
Considering the burden of potentially preventable
hypertension on health services in South Africa, the
government’s population-level advance towards making
the food supply healthier is innovative. The current
study adopts a novel approach to evaluate this public
health policy in a cost-efficient and pragmatic manner,
generating information relevant to other countries, as
sodium legislation is increasingly being adopted by
governments across the globe.
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